Stock Price Movements

Search documents
Curious about Trustmark (TRMK) Q2 Performance? Explore Wall Street Estimates for Key Metrics
ZACKS· 2025-07-21 14:21
Summary of Trustmark's Upcoming Earnings Report Core Viewpoint - Trustmark (TRMK) is expected to report quarterly earnings of $0.86 per share, reflecting a year-over-year increase of 30.3%, with revenues projected at $201.33 million, an 8.3% increase from the previous year [1]. Earnings Projections - There have been no revisions in the consensus EPS estimate over the last 30 days, indicating stability in analysts' forecasts [1][2]. Key Metrics Forecast - Analysts predict the 'Efficiency Ratio' to reach 62.7%, down from 63.8% in the same quarter last year [4]. - The estimated 'Total nonaccrual LHFI' is projected at $87.77 million, significantly higher than the $44.29 million reported in the same quarter last year [4]. - 'Total nonperforming assets' are expected to be $98.06 million, compared to $50.88 million a year ago [5]. - 'Average Balances - Total earning assets' are forecasted to be $16.88 billion, slightly lower than the $17.19 billion from the previous year [5]. - 'Net Interest Income' is anticipated to reach $156.91 million, up from $141.03 million in the same quarter last year [6]. - 'Net Interest Income (FTE)' is projected at $159.15 million, compared to $144.33 million a year ago [6]. Stock Performance - Trustmark shares have returned +13.1% over the past month, outperforming the Zacks S&P 500 composite's +5.4% change, indicating a positive market outlook [6].
Gear Up for Philip Morris (PM) Q2 Earnings: Wall Street Estimates for Key Metrics
ZACKS· 2025-07-17 14:15
Core Viewpoint - Philip Morris is expected to report quarterly earnings of $1.85 per share, reflecting a 16.4% increase year-over-year, with revenues projected at $10.25 billion, an 8.3% increase from the previous year [1]. Earnings Projections - Analysts have revised the consensus EPS estimate 0.5% higher over the last 30 days, indicating a collective reevaluation of initial estimates [1][2]. Revenue Estimates - The estimated 'Net Revenues- Smoke-Free Excl. W&H- Total' is projected at $4.23 billion, showing a year-over-year change of +19.7% [4]. - 'Net Revenues- Combustible Tobacco- Total' is expected to reach $6.08 billion, indicating a +3.8% change from the prior-year quarter [4]. - 'Net Revenues by Geography- EA, AU & PMI DF' is forecasted at $1.77 billion, reflecting a +6.1% year-over-year change [5]. - 'Net Revenues by Geography- Europe' is anticipated to be $4.26 billion, with an +11.8% change from the previous year [5]. - 'Net Revenues by Geography- SSEA, CIS & MEA' is estimated at $2.93 billion, indicating a +5.9% change [5]. - 'Net Revenues by Geography- Americas' is projected to reach $1.33 billion, reflecting a +17.8% change from the prior-year quarter [6]. Shipment Volume Estimates - 'Shipment Volume - Cigarettes and HTUs - Total' is expected to be 195.25 billion, compared to 193.16 billion in the same quarter last year [6]. - 'Shipment Volume - EA, AU & PMI DF - Total' is projected at 27.10 billion, slightly down from 27.35 billion year-over-year [7]. - 'Shipment Volume - SSEA, CIS & MEA - Total' is expected to be 95.56 billion, compared to 94.33 billion in the same quarter last year [7]. - 'Shipment Volume - Americas - Total' is forecasted to reach 16.46 billion, up from 15.09 billion in the same quarter last year [8]. - 'Shipment Volume - Cigarettes and HTUs - Heated Tobacco Units' is projected at 38.37 billion, compared to 35.54 billion in the same quarter last year [8]. - 'Shipment Volume - Americas - Cigarettes' is expected to be 14.59 billion, slightly down from 14.89 billion year-over-year [9]. Market Performance - Philip Morris shares have shown a return of +0.4% over the past month, while the Zacks S&P 500 composite has changed by +4.2% [10].
CRA (CRAI) Surges 3.0%: Is This an Indication of Further Gains?
ZACKS· 2025-07-15 13:40
Company Overview - CRA International (CRAI) shares increased by 3% to $202.84 in the last trading session, with a notable volume of shares traded, contributing to a total gain of 9% over the past four weeks [1] - The stock is experiencing strong momentum, characterized by record-breaking performance and broad-based practice growth [1] Earnings Expectations - CRA is projected to report quarterly earnings of $1.83 per share, unchanged from the same quarter last year, with expected revenues of $179.7 million, reflecting a 4.8% increase year-over-year [2] - The consensus EPS estimate for CRA has remained stable over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [3] Industry Context - CRA operates within the Zacks Consulting Services industry, which includes other companies like Stantec (STN), whose shares rose by 1.2% to $111.81 in the last trading session, with a 3.5% return over the past month [4] - Stantec's consensus EPS estimate has also remained unchanged at $0.98, representing a 19.5% increase from the previous year [5]
Gear Up for Webster Financial (WBS) Q2 Earnings: Wall Street Estimates for Key Metrics
ZACKS· 2025-07-14 14:16
Core Viewpoint - Analysts expect Webster Financial (WBS) to report quarterly earnings of $1.41 per share, reflecting an 11.9% year-over-year increase, with revenues projected at $711.74 million, up 15.8% from the previous year [1] Earnings Projections - The consensus EPS estimate has been revised down by 0.2% in the past 30 days, indicating a reassessment by covering analysts [1][2] Key Financial Metrics - Analysts predict a 'Net Interest Margin' of 3.4%, up from 3.2% in the same quarter last year [4] - The 'Efficiency Ratio' is estimated at 47.6%, compared to 46.2% a year ago [4] - 'Average balance - Total interest-earning assets' is expected to be $72.96 billion, an increase from $68.86 billion in the same quarter last year [5] - 'Total nonperforming loans and leases' are projected to be $587.42 million, up from $368.84 million a year ago [5] Income Estimates - 'Total Non-Interest Income' is expected to reach $93.59 million, significantly higher than $42.30 million reported in the same quarter last year [6] - 'Net Interest Income' is projected at $616.23 million, compared to $572.30 million in the same quarter last year [6] - 'Wealth and investment services' are expected to be $7.86 million, down from $8.56 million a year ago [7] - 'Loan and lease related fees' are estimated at $17.97 million, lower than $19.33 million reported last year [7] - 'Deposit service fees' are forecasted to be $39.51 million, down from $41.03 million a year ago [8] - 'Increase in cash surrender value of life insurance policies' is estimated at $8.02 million, up from $6.36 million last year [8] - 'Non-interest income - Other income' is projected to reach $20.35 million, compared to $16.94 million a year ago [8] Overall Performance - Over the past month, shares of Webster Financial have increased by 13.4%, outperforming the Zacks S&P 500 composite's 4% change [9] - Currently, WBS holds a Zacks Rank 3 (Hold), suggesting its performance may align with the overall market in the near future [9]
Stay Ahead of the Game With South Plains Financial (SPFI) Q2 Earnings: Wall Street's Insights on Key Metrics
ZACKS· 2025-07-11 14:16
Core Viewpoint - South Plains Financial (SPFI) is expected to report quarterly earnings of $0.77 per share, a 16.7% increase year-over-year, with revenues projected at $51.7 million, reflecting a 6.4% growth compared to the previous year [1]. Earnings Projections - The consensus EPS estimate has been revised 2.4% lower in the last 30 days, indicating a collective reevaluation by analysts [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Key Financial Metrics - The consensus estimate for the 'Efficiency ratio' is 64.7%, down from 66.7% a year ago [5]. - 'Nonperforming Loans' are expected to reach $7.70 million, a significant decrease from $23.45 million reported in the same quarter last year [5]. - 'Net Interest Margin (FTE)' is forecasted at 3.8%, up from 3.6% in the same quarter of the previous year [5]. - 'Average Balance - Total interest-earning assets' is estimated at $4.15 billion, compared to $4.00 billion reported last year [6]. - 'Net Interest Income' is projected at $39.59 million, an increase from $35.89 million reported in the same quarter last year [6][7]. - 'Total Noninterest Income' is expected to be $12.11 million, slightly down from $12.71 million a year ago [7]. Stock Performance - Over the past month, shares of South Plains Financial have returned +2.7%, while the Zacks S&P 500 composite has changed by +4.1% [7]. - Currently, SPFI holds a Zacks Rank 4 (Sell), suggesting potential underperformance relative to the overall market in the near future [7].
Stay Ahead of the Game With M&T Bank (MTB) Q2 Earnings: Wall Street's Insights on Key Metrics
ZACKS· 2025-07-11 14:16
Core Viewpoint - Analysts project that M&T Bank Corporation (MTB) will report quarterly earnings of $4.03 per share, a 6.3% increase year over year, with revenues expected to reach $2.39 billion, up 3.6% from the same quarter last year [1]. Earnings Projections - The consensus EPS estimate has been revised down by 0.2% in the past 30 days, indicating a reassessment by covering analysts [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Key Financial Metrics - Analysts forecast the 'Efficiency Ratio' to be 56.3%, compared to 55.3% a year ago [4]. - The 'Net Interest Margin' is expected to reach 3.7%, up from 3.6% in the same quarter last year [5]. - The 'Average Balance - Total Earning Assets' is projected at $191.73 billion, down from $193.68 billion year over year [5]. - The 'Tier 1 Leverage' is estimated at 10.1%, slightly up from 10.0% a year ago [5]. - The 'Tier 1 Capital Ratio' is expected to be 12.9%, down from 13.2% year over year [6]. - The 'Total Capital Ratio' is projected at 14.6%, compared to 14.9% a year ago [6]. - 'Total Other Income' is estimated at $638.93 million, up from $584.00 million year over year [6]. Revenue Estimates - The consensus for 'Net Interest Income - Taxable-Equivalent' stands at $1.76 billion, compared to $1.73 billion in the same quarter last year [7]. - 'Service Charges on Deposit Accounts' are estimated at $135.70 million, up from $127.00 million year over year [7]. - 'Trust Income' is projected to reach $181.34 million, compared to $170.00 million in the same quarter last year [8]. - 'Mortgage Banking Revenues' are expected to be $126.99 million, up from $106.00 million year over year [8]. - 'Net Interest Income' is anticipated to be $1.74 billion, compared to $1.72 billion a year ago [9]. Stock Performance - Over the past month, M&T Bank shares have returned +10.9%, outperforming the Zacks S&P 500 composite's +4.1% change [9].
Vir Biotechnology (VIR) Soars 11.9%: Is Further Upside Left in the Stock?
ZACKS· 2025-07-10 14:35
Company Overview - Vir Biotechnology, Inc. (VIR) shares increased by 11.9% to close at $5.93, with trading volume significantly higher than usual, contrasting with a 2.2% loss over the past four weeks [1][2] Pipeline and Development - The rise in stock price is linked to positive investor sentiment regarding tobevibart, Vir Biotechnology's late-stage pipeline candidate, which is in a phase III ECLIPSE 1 study for chronic hepatitis delta (CHD) treatment [2] - The company is preparing to start a phase III ECLIPSE 2 study to evaluate the efficacy and safety of switching to tobevibart and elebsiran for CHD patients not achieving viral suppression with bulevirtide [2] Financial Expectations - The upcoming quarterly report is expected to show a loss of $0.74 per share, reflecting a year-over-year increase of 27.5%, while revenues are projected at $7.05 million, up 128.8% from the previous year [3] - The consensus EPS estimate for the quarter has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [4] Industry Context - Vir Biotechnology operates within the Zacks Medical - Biomedical and Genetics industry, which includes other companies like Opus Genetics, Inc. (IRD), that also has a Zacks Rank of 2 (Buy) [4][5]
Granite Ridge Resources, Inc. (GRNT) Surges 6.7%: Is This an Indication of Further Gains?
ZACKS· 2025-06-23 11:40
Company Overview - Granite Ridge Resources, Inc. (GRNT) shares increased by 6.7% to close at $6.41, supported by higher trading volume compared to normal sessions [1] - The company is positioned to benefit from rising oil prices due to geopolitical tensions, particularly the conflict between Israel and Iran, which has led to a 13% increase in Brent crude and a 10% increase in West Texas Intermediate (WTI) [2] Financial Performance - Granite Ridge is expected to report quarterly earnings of $0.17 per share, reflecting a year-over-year increase of 30.8%, with revenues projected at $111 million, up 22.5% from the previous year [3] - The consensus EPS estimate for Granite Ridge has remained unchanged over the last 30 days, indicating stability in earnings expectations [4] Market Position - The company operates as a non-operated oil and natural gas exploration and production entity with a diverse portfolio across major U.S. basins, which enhances its operational flexibility and attractiveness in a volatile market [2] - Granite Ridge holds a Zacks Rank of 3 (Hold), indicating a neutral outlook in the current market context [5]
Wall Street's Insights Into Key Metrics Ahead of Guidewire Software (GWRE) Q3 Earnings
ZACKS· 2025-05-29 14:21
Core Viewpoint - Guidewire Software (GWRE) is expected to report significant growth in earnings and revenues for the upcoming quarter, with analysts projecting earnings of $0.46 per share and revenues of $285.72 million, reflecting year-over-year increases of 76.9% and 18.7% respectively [1] Earnings Projections - Analysts predict quarterly earnings of $0.46 per share, marking a 76.9% increase from the same period last year [1] - The consensus EPS estimate has remained unchanged over the past 30 days, indicating stability in analysts' projections [1] Revenue Estimates - Total revenues are forecasted to be $285.72 million, representing an 18.7% year-over-year increase [1] - 'Revenue- Subscription and support' is expected to reach $178.14 million, a 29.1% increase from the prior year [4] - 'Subscription Revenue' is projected at $162.74 million, indicating a 35.1% increase from the previous year [4] - 'Revenues- License' is estimated to be $55.33 million, reflecting a slight decrease of 1.6% from the prior year [4] Service and Support Revenue - 'Revenues- Services' is projected to be $52.00 million, showing an 11.8% year-over-year increase [5] - 'Support Revenue' is expected to decline to $15.41 million, a decrease of 12.2% from the previous year [5] - 'Term License Revenue' is estimated at $54.48 million, indicating a 1% decrease year-over-year [5] Annual Recurring Revenue - The consensus estimate for 'Annual recurring revenue' stands at $944.40 million, up from $828 million a year ago [6] Gross Profit Estimates - 'Gross profit- Subscription and support' is expected to be $120.51 million, compared to $86.79 million reported in the same quarter last year [6] - 'Gross profit- License' is projected to reach $54.87 million, slightly down from $55.37 million reported in the same quarter last year [7] Stock Performance - Guidewire Software shares have increased by 1.9% over the past month, while the Zacks S&P 500 composite has risen by 6.7% [7] - The company holds a Zacks Rank 3 (Hold), suggesting it is expected to closely follow overall market performance in the near term [7]
Countdown to Synopsys (SNPS) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
ZACKS· 2025-05-23 14:22
Core Insights - Wall Street analysts forecast Synopsys (SNPS) to report quarterly earnings of $3.39 per share, reflecting a year-over-year increase of 13% [1] - Anticipated revenues for Synopsys are projected to be $1.6 billion, indicating a 10.1% increase compared to the same quarter last year [1] - The consensus EPS estimate has remained unchanged over the past 30 days, suggesting a reassessment of projections by covering analysts [1] Revenue Estimates - Revenue from Maintenance and Service is expected to reach $279.24 million, showing a year-over-year change of +1% [3] - Total Products Revenue is estimated at $1.32 billion, indicating a +12.3% change from the prior-year quarter [4] - Revenue by segment for Design IP is projected to be $443.37 million, reflecting a +10.9% change from the year-ago quarter [4] - Revenue by segment for Design Automation is anticipated to reach $1.16 billion, indicating a +9.9% change from the prior-year quarter [4] - Upfront Products revenue is forecasted at $415.15 million, suggesting a +4.7% year-over-year change [5] - Time-based Products revenue is expected to come in at $904.12 million, reflecting a +15.7% change from the year-ago quarter [5] Stock Performance - Synopsys shares have increased by +14.7% in the past month, outperforming the Zacks S&P 500 composite, which has moved up by +10.7% [6] - The company holds a Zacks Rank 3 (Hold), indicating it is expected to closely follow overall market performance in the near term [6]